In addition, the levels of IFN-γ and IL-2 in patients with acute COVID-19 (≥55 years old) are low, and the activation of T cells derived from dendritic cells is impaired, which will also lead to a reduced adaptive immune response (25). The gene discussed is IL2; the disease is COVID-19.